Medicortex was granted a European patent for biomarker diagnostics

Adrian Harel (adrian.harelmedicortex.fi), Jan 24^th 2024

Medicortex's biomarker diagnostics patent “A Method for Determining a Lectin-binding Glycan Indicative to Traumatic Brain Injury” was granted by the European Patent Office (EP patent No. 4133279). The patent protects a technique for detecting certain carbohydrates in a sample, allowing for non-invasive analysis of a bodily fluid, such as urine or saliva, for the presence and the level of biomarkers that are indicative of TBI.

Read the press release here.